CAS: 536-25-4; Methyl 3-Amino-4-Hydroxybenzoate

该化合物是分子式C8H9NO3的有机化合物,其特征是存在一个甲基酯组,一个氨基氨基组和一个附属于苯环的氢氧化物组,该化合物看起来像一种白色晶状粉,在酒精中可溶解,在水中可略易溶.甲基丙烯因其抗微生物特性而广泛用作化妆品,药品和食品中的防腐剂,这有助于抑制细菌和真菌的生长.一般认为在适当浓度下使用该化合物是安全的,尽管有些人可能会经历过敏反应.该化合物的熔点一般属于特定范围,其稳定性可能受诸如pH和温度等因素的影响.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

3-氨基-4-羟基苯甲酸 3-Amino-4-Hydroxybenzoic Acid 1571-72-8
3-硝基-4-羟基苯甲酸甲酯 Methyl (4-Hydroxy-3-Nitro)Benzoate 99-42-3
对羟基苯甲酸甲酯 Methyl 4-Hydroxybenzoate 99-76-3
4-羟基-3-硝基苯甲酸 3-Nitro-4-Hydroxybenzoic Acid 616-82-0
1-(3-氨基-4-羟基苯基)乙酮 3-Amino-4-Hydroxyacetophenone 54255-50-4

合成工艺路线路线简述

  • 合成目标产物 Methyl 3-Amino-4-Hydroxybenzoate 主要起始原料 Methanol And 3-Amino-4-Hydroxybenzoic Acid
  • (文献来源)合成步骤主要原料 Methanol 和 3-Amino-4-Hydroxybenzoic Acid
4-羟基-3-硝基苯甲酸置于氯化亚砜,Palladium On Activated Charcoal,氢气体系中,用 甲醇 作为反应溶剂,化学反应生成 3-氨基-4-羟基苯甲酸甲酯
参考文献:Nocarbenzoxazole G的合成,结构修订和细胞毒性.
标题:Nocarbenzoxazole G的合成,结构修订和细胞毒性.
摘要:最初从海洋衍生的嗜盐细菌菌株nocardiopsis Lucentensis Dsm 44048获得的去甲苯并恶唑f(1)和g(2)的总合成是通过一种简单而通用的方法实现的,该方法涉及微波辅助构建苯并恶唑骨架与相应的芳基溴形成碳-碳键.不幸的是,天然去甲苯并恶唑g的1H和13C NMR光谱与合成化合物的光谱不一致.特别地,分离和合成的化合物的光谱显示出来自芳基中的质子和碳的信号的显着差异.通过实际合成的去甲苯并恶唑g(8C)分子的全合成来验证修订后的结构,该分子是该化合物的区域异构体,之前被报道为去甲苯并恶唑g.
DOI:10.1021/acs.Jnatprod.9B00072

海关参考信息

专利信息


专利号:US-11325912-B2
优先权日:2019-05-09
标题 :Regio-selective synthesis of imidazo[1,2-a]pyrimidines
发明人:CLAGG KYLE BRADLEY PASCUAL; WHITE NICHOLAS ANDREW; ZHANG HAIMING; GOSSELIN FRANCIS; NACK WILLIAM; O'SHEA PAUL D
权利人:GENENTECH INC
摘要:A method of regio-selectively synthesizing an imidazo-pyrimidine compound of formulae (XXa) or (XXb)comprising a step of coupling a first compound of formula XX-P1a or XX-P1b with a second compound of formula XX-P2This annulation reaction between β-ethoxy acrylamides and phosphorylated aminoimidazoles to furnish imidazo[1,2-a]pyrimidin-amines relies on steering effects from endocyclic and exocyclic phosphorylated aminoimidazoles. The reaction furnishes either 2-amino or 4-amino constitutional isomers of imidazo[1,2-a]pyrimidines with good yields and ranges of 90:10-99:1 regio-selectivity. The reaction is useful in the synthesis of various tracer molecules used in the study of neurological conditions such as where R3 and R4 together with the imidazole ring atoms to which they are bonded form a phenyl ring and the products are substituted benzimidazopyrimidines. The reaction can be generalized to form imidazo[1,2-a]pyrimidines substituted at either of their 2- and 4-positions by alkoxy or thioalkyl groups.

专利号:US-3898264-A
优先权日:1970-08-26
标题:Steroid total synthesis process utilizing a cyanoalkyl A-ring precursor
发明人:COHEN NOAL; ROSENBERGER MICHAEL; SAUCY GABRIEL
权利人:HOFFMANN LA ROCHE
摘要:A multi-step, stereospecific total synthesis of steroids utilizing intermediates having a cyanoalkyl A-ring precursor is disclosed. The initial starting materials for this process are the relatively inexpensive and commercially available reagents gamma -butyrolactone and sodium cyanide. The process is suitable for the preparation of racemic or optically active, medicinally valuable steroids, particularly 19-norsteroids. It is a feature of this process that conditions employed during the multiple step synthesis are selected so as to retain the normally labile nitrile group even during hydrogenation and hydrolysis steps. In this manner, it is possible to employ the nitrile group as an Aring precursor without resorting to protective groups as was heretofore found necessary in previous steroid total synthesis processes.

专利号:US-2025073250-A1
优先权日:2022-01-05
标题:Improved synthesis of lysine acetylsalicylate - Glycine particles
发明人:NOCKER KARLHEINZ; ZUHSE RALF; VON SCHRADER THOMAS; BRAUNE CHRISTIAN
权利人:ASPIAIR GMBH
摘要:The invention provides an improved method for preparing lysine acetylsalicylateâ‹…glycine (LASAG) that allows for high yields without the need for an addition of seed crystal, as well as yielding controlled, small particle sizes (median particles size preferably <40 μm) and high stability of the LASAG. Advantageously, the method can be performed at room temperature without negatively impacting yield or particle properties. The invention also provides the LASAG obtained from said method, and its uses as a medicine.

专利号:US-3607338-A
优先权日:1968-04-11
标 题 :Synthesis of zinc titanate pigment and coatings containing the same
发明人:GATES DANIEL W; ZERLAUT GENE A; ROGERS FREDERICK O
权利人:NASA
摘要:Zinc titanate pigment resistant to degradation of reflective properties upon exposure to ultraviolet radiation in vacuum is prepared by reacting zinc oxide with anatase titanium dioxide at a molar ratio of 2:1 and a temperature of at least 900* C. and contacting the product with a zinc oxide extractant solution. The pigment prepared by this process is combined with a suitable binder to produce degradation-resistant coatings.

专利号:US-7390801-B2
优先权日:1996-12-23
标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
发明人:THORSETT EUGENE D; PLEISS MICHAEL A; LATIMER LEE H; JOHN VARGHESE; FREEDMAN STEPHEN; BRITTON THOMAS C; AUDIA JAMES A; REEL JON K; DRESSMAN BRUCE A; DROSTE JAMES J; HENRY STEVEN S; STUCKY RUSSELL D; PORTER WARREN J
权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:WO-2023131645-A1
优先权日:2022-01-05
标 题 :Improved synthesis of lysine acetylsalicylate · glycine particles
江苏贵仁医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.guirenchem.com
电话:0519-83489086;13601507568👤
📞 江苏贵仁医药有限公司⚠️参考联系方式

电话: 0519-83489086;13601507568
邮件:sales@guirenchem.com
网址: http://www.guirenchem.com
地址:江苏省常州市芮城县风陵渡开发区振兴北街北侧
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

江苏省常州市芮城县风陵渡开发区振兴北街北侧
⚠️ 未注册 · 未认证企业
注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Gary W. Cleary, Et Al. Compositions And Delivery Systems For Administration Of A Local Anesthetic Agent. Patent Wo2002089849A1.

合成参考文献


摘要:Schnürch, M.; Hämmerle, J.; Stanetty, P., Science of Synthesis Knowledge Updates, (2010) 1, 162.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知